Amlexanox Anti-Inflammatory Peptide
No pricing data available yet for this peptide.
Pricing data is updated regularly.
Amlexanox inhibits TBK1 and IKKε kinases, reducing chronic low-grade inflammation associated with obesity. It reverses metabolic dysfunction, improves insulin sensitivity, promotes thermogenesis in brown adipose tissue, and has shown significant weight loss effects in preclinical studies.
| Level | Amount | Frequency | Timing |
|---|---|---|---|
| Beginner | 25 mg | Twice daily | With meals |
| Standard | 50 mg | Three times daily | With meals |
| Advanced | 100 mg | Three times daily | Under medical supervision |
8-12 weeks, ongoing with monitoring
~3 hours
Usually oral tablets
Room temperature
N/A for oral form
Explore peer-reviewed studies and clinical research on Amlexanox
Peer-reviewed medical research
Active and completed clinical trials
Academic papers and citations
Evidence-based supplement analysis
Research Disclaimer: These links lead to external research databases. Always consult with a qualified healthcare provider before making decisions based on research literature.
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Consult a licensed healthcare professional before using any peptide. BioProtocol does not sell peptides or pharmaceutical products.